Riskpilot← Back to searchSign inGet full accessCystotech ApS
APSActiveCVR 42773565Inge Lehmanns Gade 10, 5.Research and experimental development on natural sciences and engineering · NACE 7210Est. 202116 employees
Revenue 2024
DKK 877K
-46% vs 2023
EBITDA margin
-459.3%
-135% vs 2023
Equity ratio
57.4%
Financial strength
Net profit 2024
DKK -3,5M
-116% vs 2023
| Revenue | DKK 877K | -46% |
| EBITDA | DKK -4M | -135% |
| Net profit | DKK -3,5M | -116% |
| Total assets | DKK 16,5M | +21% |
| Equity | DKK 9,5M | +25% |
| Employees | 16 | — |
Legal name
Cystotech ApS
CVR number
42773565
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20. oktober 2021
Share capital
DKK 77.057
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør, af to bestyrelsesmedlemmer eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive udviklings- og forskningsvirksomhed indenfor det sundhedsfaglige område samt efter bestyrelsens skøn dermed beslægtet virksomhed.
Address
Inge Lehmanns Gade 10, 5.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 765 | 1.612 | 877 |
| Staff expenses | -1.390 | -3.326 | -4.907 |
| EBITDA | -625 | -1.714 | -4.030 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -625 | -1.714 | -4.030 |
| Net financials | -183 | -402 | -465 |
| Profit before tax | -808 | -2.116 | -4.495 |
| Tax | -270 | -519 | -1.041 |
| Net profit | -538 | -1.597 | -3.454 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 8.153 | 13.621 | 16.540 |
| Equity | 4.119 | 7.603 | 9.495 |
| Long-term debt | 3.107 | 3.525 | 4.009 |
| Short-term debt | 891 | 2.285 | 2.997 |
| Total debt | 3.998 | 5.810 | 7.006 |
EBITDA margin
-459.3%
This company
15.8%
Market median
-3007% vs market
20222024
Equity ratio
57.4%
This company
38.2%
Market median
+50% vs market
20222024
Return on equity
-36.4%
This company
18.4%
Market median
-298% vs market
20222024
Net profit margin
-393.7%
This company
8.1%
Market median
-4960% vs market
20222024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20222024
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2021-10-20 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AM Management | Management | 2025 | — | — |
CH Management | Management | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Cajbo ApS | Company | 20.0% | 20.0% | 2024 |
Cloudbeam Holding ApS | Company | 10.0% | 10.0% | 2023 |
Cystotech Invest ApS | Company | 10.0% | 10.0% | 2024 |
Skovly-Munk Holding ApS | Company | 10.0% | 10.0% | 2023 |
Cystotech Invest II ApS | Company | 5.0% | 5.0% | 2025 |
Den Midtjyske Iværksætterfond | Company | 5.0% | 5.0% | 2023 |
CH MEDINVEST ApS | Company | 5.0% | 5.0% | 2023 |
h6capital ApS | Company | 5.0% | 5.0% | 2023 |
INNOVATIONS A/S | Company | 5.0% | 5.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CH MEDINVEST ApS
Cystotech ApS Board members of Cystotech ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Munk Nielsen | Management | 0 companies |
| Claus Hansen | Management | 0 companies |
| Lars Christian Lund | Chairman | 0 companies |
| Nazarena Mazzaro | Board of Directors | 0 companies |
| Ole Niels Jakob Jensen | Board of Directors | 0 companies |
| Jacob Elmose Jensen | Board of Directors | 0 companies |
| Brian Hedegaard | Board of Directors | 0 companies |